Lazarus Rochelle B - Jun 9, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Director
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Rochelle B. Lazarus
Stock symbol: OGN
Transactions as of: Jun 9, 2023
Transactions value $: $200,005
Form type: 4
Date filed: 6/13/2023, 04:54 PM
Previous filing: Jul 11, 2022
Next filing: Jul 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
holding	OGN	Common Stock						458	Jun 9, 2023	Direct
holding	OGN	Common Stock						175	Jun 9, 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Phantom Stock	+Grant/Award	$200,005	+10,086	+66.36%	$19.83	25,285	Jun 9, 2023	Common Stock	10,086		Direct	F1, F2, F3

Explanation of Responses:

Id	Content
F1	Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2	Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3	Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023.